Evidence map›Paper›PMID 26974749›Full record

ArticleThe Pediatric infectious disease journal2016

Bacterial Density, Serotype Distribution and Antibiotic Resistance of Pneumococcal Strains from the Nasopharynx of Peruvian Children Before and After Pneumococcal Conjugate Vaccine 7.

Christiane R Hanke, Carlos G Grijalva, Sopio Chochua, Mathias W Pletz, Claudia Hornberg, Kathryn M Edwards, Marie R Griffin, Hector Verastegui, Ana I Gil, Claudio F Lanata and 2 more

Open access · greenAbstract read
In one paragraph

Article in The Pediatric infectious disease journal, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
4.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 33 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. The Crisis of Macrolide Resistance in Pneumococci in Latin America.The American journal of tropical medicine and hygiene · 2024
    Review
  7. Increase of Macrolide-Resistance inFrontiers in cellular and infection microbiology · 2022
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Observational
  18. Dynamics of Colonization ofOpen forum infectious diseases · 2018
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Christiane R HankeFrom the *Hubert Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, Georgia; †Department of Health Policy, School of Medicine, Vanderbilt University, Nashville, Tennessee; ‡Center for Infectious Diseases and Infection Control, Jena University Hospital, Jena, Germany; §Department of Environment and Health, School of Public Health, Bielefeld University, Bielefeld, Germany, ¶Vanderbilt Vaccine Research Program, Division of Infectious Diseases, Department of Pediatrics, Vanderbilt University School of Medicine, Nashville, Tennessee; and ‖Instituto de Investigación Nutricional, Lima, Perú.
Carlos G Grijalva
Sopio Chochua
Mathias W Pletz
Claudia Hornberg
Kathryn M Edwards
Marie R Griffin
Hector Verastegui
Ana I Gil
Claudio F Lanata
Keith P Klugman
Jorge E Vidal
American Society for Microbiology · US

Funding

VANDERBILT UNIVERSITY CTSA FOR PEDIATRIC RESEARCHUL1RR024975 · NCRR · VANDERBILT UNIVERSITY · PI BERNARD, GORDON RAPHAEL · 2007 to 2011
$45.7M
NCRR NIH HHS UL1 RR024975
6 · The paper itself

Abstract

backgroundPneumococcal conjugate vaccines (PCV) have decreased nasopharyngeal carriage of vaccine types but little data exist from rural areas. We investigated bacterial density, serotype distribution and antibiotic resistance of pneumococcal strains within the nasopharynx of young children in the Peruvian Andes, 2 years after PCV7 was introduced.

methodsPneumococcal strains were isolated from a subset of 125 children from our Peruvian cohort, who entered the study in 2009 and had pneumococcus detected in the nasopharynx in both 2009 and during follow-up in 2011. Strains were Quellung serotyped and tested for susceptibility to antibiotics. Bacterial density was determined by quantitative polymerase chain reaction.

resultsThe prevalence of PCV7 strains decreased from 48% in 2009 to 28.8% in 2011, whereas non-PCV7 types increased from 52% to 71.2% (P = 0.002). There was a 3.5-fold increase in carriage of serotype 6C in 2011 (P = 0.026). Vaccination with PCV7 did not affect pneumococcal density in children colonized by a PCV7 type but did increase density in those colonized with a non-PCV7 type. Antibiotic resistance did not change after vaccine introduction; strains were nonsusceptible to tetracycline (97.2%), trimethoprim-sulfamethoxazole (56.4%), penicillin (34%), erythromycin (22.4%), chloramphenicol (18.8%) and clindamycin (12.4%).

conclusionsSerotype replacement was observed post-PCV7 vaccination with a concomitant, not previously recognized, increased nasopharyngeal density.

Indexed as

Drug Resistance, BacterialSerogroupAnti-Bacterial AgentsBacterial LoadChild, PreschoolCross-Sectional StudiesFemaleHeptavalent Pneumococcal Conjugate VaccineHumansInfantMaleMicrobial Sensitivity TestsNasopharynxPeruPneumococcal InfectionsPrevalenceAnti-Bacterial AgentsHeptavalent Pneumococcal Conjugate Vaccine

Identifiers

PMID26974749
PMCPMC4820239
OpenAlexW2299345761

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.